Which companies overlap with Beijing Center for Disease Control and Prevention's portfolio?

Top competitors by shared drug class: Centers for Disease Control and Prevention, Institute of Medical Biology, Chinese Academy of Medical Sciences, Bandim Health Project, Canadian Immunization Research Network, Chinese Academy of Medical Sciences.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-center-for-disease-control-and-prevention.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Beijing Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beijing Center for Disease Control and Prevention pipeline: 14 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

14 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
HBV-3	HBV-3	marketed			Other
HBV-6	HBV-6	marketed			Other
Aleph influenza vaccine	Aleph influenza vaccine	marketed	vaccine		Immunology
varicella-3	varicella-3	marketed	Live attenuated vaccine	Varicella-zoster virus	Immunology / Infectious Disease
Zagreb2-1-1	Zagreb2-1-1	marketed
vaccine without gelatin	vaccine without gelatin	marketed	vaccine		Immunology
imported compared vaccine	imported compared vaccine	marketed	vaccine		Immunology
Inoculation in upper arm deltoid	Inoculation in upper arm deltoid	marketed	vaccine		Immunology
domestic compared vaccine	domestic compared vaccine	marketed	vaccine		Immunology
varicella-6	varicella-6	marketed	Live attenuated vaccine	Varicella-zoster virus	Immunology / Infectious Disease
evaluated vaccine	evaluated vaccine	marketed			Immunology
vaccine with gelatin	vaccine with gelatin	marketed	vaccine		Immunology

Therapeutic area mix

Immunology · 8
Other · 3
Immunology / Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centers for Disease Control and Prevention · 2 shared drug classes
Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 shared drug classes
Bandim Health Project · 2 shared drug classes
Canadian Immunization Research Network · 2 shared drug classes
Chinese Academy of Medical Sciences · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Aga Khan University · 2 shared drug classes
International Centre for Diarrhoeal Disease Research, Bangladesh · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Beijing Center for Disease Control and Prevention:

Cite this brief

Drug Landscape (2026). Beijing Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-center-for-disease-control-and-prevention. Accessed 2026-05-16.